论文部分内容阅读
上榜理由:通过今日投资“分析师实时排名”系统对业内4000名分析师的追溯跟踪,广发证券分析师葛峥在“最牛分析师”医疗保健与服务行业排行榜中近1年名列第1位,获得我们评选的第114期“每周一星”称号。近期主要观点:上半年医药上市公司收入、营业利润(主业)、净利润、扣除非经常损益后净利润分别同比增长22%、10%、21%和7%。上半年经营主要呈现以下特征:1、第二季度的收入及利润增速并未放慢;2、由于
Ranking reasons: through today’s investment “analyst real-time rankings ” system on the tracing back of 4000 analysts in the industry, GF Securities analyst Ge Zheng in the “most cattle analyst ” health care and service industry rankings in the near 1 year ranked No. 1, won our selection of the 114th “one star per week ” title. Recent main points: In the first half of the year, the revenue of pharmaceutical listed companies, operating profit (main business), net profit and net profit after deducting non-recurring gains and losses increased by 22%, 10%, 21% and 7% respectively. In the first half of the year, the main features are as follows: 1. The revenue and profit growth in the second quarter did not slow down. 2. Due to